SCHEMBL3135246

SCHEMBL3135246

COc1cccc(/C=C/CCCCC(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 2/20 0.58
LTB4R2 Q9NPC1 2/20 0.58
TBXAS1 P24557 1/20 0.54
FOS P01100 1/20 0.52
JUN P05412 1/20 0.52
BCHE P06276 1/20 0.52
GRIK1 P39086 1/20 0.52
GRIK2 Q13002 1/20 0.52
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51
CHRM3 P20309 1/20 0.51
FFAR1 O14842 1/20 0.49
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49
MAOB P27338 2/20 0.49
LMNA P02545 1/20 0.49
RELA Q04206 1/20 0.48
DRD3 P35462 1/20 0.48
FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135249 1.00 LTB4R (0.58) LTB4RLTB4R2TBXAS1FOSJUN
SCHEMBL12500127 0.96 LTB4R (0.54) LTB4RLTB4R2TBXAS1FOSJUN
SCHEMBL5388778 0.90 FOS (0.56) FOSJUNBCHEGRIK1GRIK2
SCHEMBL5388781 0.90 FOS (0.56) FOSJUNBCHEGRIK1GRIK2
SCHEMBL8003031 0.83 LTB4R (0.70) LTB4RLTB4R2TBXAS1GRIK1GRIK2
SCHEMBL8080134 0.82 LTB4R (0.69) LTB4RLTB4R2TBXAS1GRIK1GRIK2
SCHEMBL1005789 0.82 LTB4R (0.69) LTB4RLTB4R2TBXAS1GRIK1GRIK2
SCHEMBL8080137 0.82 LTB4R (0.69) LTB4RLTB4R2TBXAS1GRIK1GRIK2
SCHEMBL1005790 0.82 LTB4R (0.69) LTB4RLTB4R2TBXAS1GRIK1GRIK2
SCHEMBL7494930 0.81 PAM (0.59) FOSJUNBCHEGRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268817-B2 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-18 US disclosed
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2010-03-25 US disclosed
EP-2068862-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2009-06-17 EP disclosed
WO-2008030532-A2 SUBSTITUTED OXAZOLE KETONE MODULATORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075931-A1 Substituted oxazole ketone modulators of fatty acid amide hydrolase FAAH, FAAH2, HCRTR2 LTB4R 449/4885LTB4R2 315/4885TBXAS1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.